ClinicalTrials.gov
ClinicalTrials.gov Menu

S9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00004137
Recruitment Status : Completed
First Posted : April 12, 2004
Last Update Posted : February 15, 2013
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2004
  Actual Study Completion Date : November 2008
Publications of Results:
Dunphy F, Hesketh P, Chansky K, et al.: Southwest Oncology Group trial (SWOG) 9914: phase II trial of paclitaxel, carboplatin and topotecan (PCT) in untreated patients (pts) with extensive small cell lung cancer (SCLC). [Abstract] Proceedings of the American Society of Clinical Oncology 21: A-1184, 2002.